• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经鼻腔给予神经毒素-II 的纳米颗粒递送至脑内:提高神经毒素的抗伤害活性的有效策略。

Nanoparticle-mediated delivery of neurotoxin-II to the brain with intranasal administration: an effective strategy to improve antinociceptive activity of neurotoxin.

机构信息

College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, P.R China.

出版信息

Drug Dev Ind Pharm. 2012 Jan;38(1):123-8. doi: 10.3109/03639045.2011.592533. Epub 2011 Jul 1.

DOI:10.3109/03639045.2011.592533
PMID:21721852
Abstract

BACKGROUND

Neurotoxin-II (NT-II), an analgesic peptide which was separated from the venom of Naja naja atra, is endowed an exceptional specificity of action that block transmission of the nerve impulse by binding to the acetylcholine receptor in the membrane. However, it has limited permeability across the blood-brain barrier (BBB) after intravenously (i.v.) injection.

METHODS

In this study, we explored the potential application of nanoparticles overcoated with polysorbate 80 (P-80-NP) as drug carrier system for the nasal delivery of NT and the antinociceptive properties of NT-loaded P-80-NP (NT-P-NP) were also evaluated.

RESULTS

The brain delivery of NT-II could be enhanced with nanoparticles coated with polysorbate-80 through intranasally (i.n.) administration. Compared with NT-II solution, NT-P-NP exhibited sustained release in vitro and higher concentrations of NT-II in the brain. The antinociceptive animal testing also revealed that intranasal delivery of NT-loaded nanoparticle coated with polysorbate-80 were able to promote better biodistribution of the drug into the brain.

CONCLUSION

The nanoparticles overcoated with polysorbate-80 were capable of transporting the loaded drug across the BBB after intranasal administration.

摘要

背景

神经毒素-II(NT-II)是从中华眼镜蛇毒液中分离出来的一种镇痛肽,具有独特的作用特异性,通过与膜上的乙酰胆碱受体结合来阻断神经冲动的传递。然而,它在静脉注射(i.v.)后穿过血脑屏障(BBB)的通透性有限。

方法

在这项研究中,我们探索了用聚山梨酯 80(P-80)包被的纳米粒作为药物载体系统经鼻给药的可能性,并且评估了载 NT 的 P-80 纳米粒(NT-P-NP)的镇痛作用。

结果

通过鼻内(i.n.)给予用聚山梨酯-80 包被的纳米粒,可增强 NT-II 的脑内传递。与 NT-II 溶液相比,NT-P-NP 在体外具有持续释放的特性,并且脑内的 NT-II 浓度更高。动物镇痛试验还表明,用聚山梨酯-80 包被的载 NT 纳米粒的鼻内给药能够促进药物更好地分布到大脑中。

结论

用聚山梨酯-80 包被的纳米粒能够在鼻内给药后将负载药物转运穿过 BBB。

相似文献

1
Nanoparticle-mediated delivery of neurotoxin-II to the brain with intranasal administration: an effective strategy to improve antinociceptive activity of neurotoxin.经鼻腔给予神经毒素-II 的纳米颗粒递送至脑内:提高神经毒素的抗伤害活性的有效策略。
Drug Dev Ind Pharm. 2012 Jan;38(1):123-8. doi: 10.3109/03639045.2011.592533. Epub 2011 Jul 1.
2
Antinociceptive properties of nasal delivery of neurotoxin-loaded nanoparticles coated with polysorbate-80.聚山梨酯 80 包裹的载神经毒素纳米颗粒经鼻腔给药的抗伤害感受特性。
Peptides. 2011 Jul;32(7):1526-9. doi: 10.1016/j.peptides.2011.05.002. Epub 2011 May 10.
3
[Polysorbate-80 modified neurotoxin nanoparticle with its transport and cytotoxicity against blood-brain barrier].[聚山梨酯80修饰的神经毒素纳米颗粒及其对血脑屏障的转运与细胞毒性]
Yao Xue Xue Bao. 2010 Oct;45(10):1312-6.
4
Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats.经鼻腔给予清醒大鼠载神经毒素 PLA 纳米粒经壳聚糖修饰后的脑药代动力学。
Drug Dev Ind Pharm. 2013 Nov;39(11):1618-24. doi: 10.3109/03639045.2012.727828.
5
[The delivery of loperamide to the brain by using polybutyl cyanoacrylate nanoparticles].[使用聚氰基丙烯酸丁酯纳米颗粒将洛哌丁胺递送至大脑]
Eksp Klin Farmakol. 1998 Jan-Feb;61(1):17-20.
6
Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route.经鼻给予利培酮固体脂质纳米粒实现脑靶向。
J Drug Target. 2011 Jul;19(6):468-74. doi: 10.3109/1061186X.2010.523787. Epub 2010 Oct 19.
7
Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity.聚(正丁基氰基丙烯酸酯)纳米粒子在体外透过血脑屏障的转运及其对屏障完整性的影响。
Biochem Biophys Res Commun. 2011 Mar 4;406(1):64-9. doi: 10.1016/j.bbrc.2011.01.110. Epub 2011 Feb 3.
8
Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.纳米粒结合阿霉素通过血脑屏障的转运动力学。
J Control Release. 2011 Aug 25;154(1):103-7. doi: 10.1016/j.jconrel.2011.05.010. Epub 2011 May 16.
9
Brain transport of neurotoxin-I with PLA nanoparticles through intranasal administration in rats: a microdialysis study.神经毒素-I与聚乳酸纳米颗粒通过鼻腔给药在大鼠体内的脑转运:一项微透析研究。
Biopharm Drug Dispos. 2008 Nov;29(8):431-9. doi: 10.1002/bdd.621.
10
Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.使用聚氰基丙烯酸丁酯纳米颗粒实现神经生长因子的脑靶向
J Drug Target. 2009 Sep;17(8):564-74. doi: 10.1080/10611860903112842.

引用本文的文献

1
Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Blume in the treatment of ischemic stroke.关于梅花草治疗缺血性中风的分子靶点及机制的网络药理学和分子对接分析
Exp Ther Med. 2022 Nov 3;24(6):742. doi: 10.3892/etm.2022.11678. eCollection 2022 Dec.
2
Effect of polysorbate 80 on the intranasal absorption and brain distribution of tetramethylpyrazine phosphate in rats.聚山梨酯 80 对磷酸川芎嗪在大鼠鼻内吸收及脑内分布的影响。
Drug Deliv Transl Res. 2019 Feb;9(1):311-318. doi: 10.1007/s13346-018-0580-y.
3
Quantum dot-mediated delivery of siRNA to inhibit sphingomyelinase activities in brain-derived cells.
量子点介导的小干扰RNA递送以抑制脑源性细胞中的鞘磷脂酶活性
J Neurochem. 2016 Dec;139(5):872-885. doi: 10.1111/jnc.13841. Epub 2016 Oct 14.
4
Delivery and tracking of quantum dot peptide bioconjugates in an intact developing avian brain.量子点肽生物共轭物在完整发育中的禽脑内的递送与追踪
ACS Chem Neurosci. 2015 Mar 18;6(3):494-504. doi: 10.1021/acschemneuro.5b00022. Epub 2015 Mar 5.
5
Recent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticles.蛋白质和肽类药物递送的最新进展:特别关注聚合物纳米颗粒
Protein Pept Lett. 2014;21(11):1102-20. doi: 10.2174/0929866521666140807114240.
6
Nanoparticle targeting to neurons in a rat hippocampal slice culture model.纳米颗粒靶向大鼠海马脑片培养模型中的神经元。
ASN Neuro. 2012 Oct 23;4(6):383-92. doi: 10.1042/AN20120042.